Erasca, Inc. (ERAS) Social Stream



Erasca, Inc. (ERAS): $2.63

0.04 (+1.54%)

POWR Rating

Component Grades

Momentum

D

Stability

C

Sentiment

Quality

C

Add ERAS to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#140 of 360

in industry

ERASCA INC (ERAS) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering ERASCA INC.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-12 5 $45 $25 $30.2 $2.16 1298.15%
2021-11-17 5 $45 $25 $30.8 $2.16 1325.93%
2022-03-24 5 $45 $19 $29.6 $2.16 1270.37%
2022-03-25 5 $45 $19 $28.8 $2.16 1233.33%
2022-04-13 5 $45 $19 $28 $2.16 1196.3%
2022-05-13 5 $45 $19 $27.4 $2.16 1168.52%
2022-05-20 5 $45 $19 $26.6 $2.16 1131.48%
2022-07-15 5 $45 $15 $25.8 $2.16 1094.44%
2022-08-13 2 $24 $15 $19.666 $2.16 810.46%
2022-11-15 3 $22 $15 $19 $2.16 779.63%
2023-01-26 3 $22 $15 $18.333 $2.16 748.75%
2023-02-08 3 $22 $15 $18.333 $2.16 748.75%
2023-02-24 3 $22 $10 $16.25 $2.16 652.31%
2023-03-24 3 $22 $10 $15.5 $2.16 617.59%
2023-04-12 4 $22 $9 $14.2 $2.16 557.41%
2023-04-19 4 $22 $9 $13.8 $2.16 538.89%
2023-05-16 5 $22 $9 $13.8 $2.16 538.89%
2023-06-06 6 $22 $9 $12.833 $2.16 494.12%
2023-08-11 6 $22 $8 $12.666 $2.16 486.39%
2023-10-11 7 $22 $8 $12.285 $2.16 468.75%
2023-11-10 6 $22 $8 $12.5 $2.16 478.7%
2023-11-28 6 $15 $7 $10 $2.16 362.96%
2023-12-19 6 $11 $7 $8.4 $2.16 288.89%

The Trend in the Analyst Price Target


ERAS's average price target has moved down $18.1 over the prior 28 months.

ERAS reports an average of 389.09% for its upside potential over the past 47 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2023-03-24 4 22 10 15.500 2.83 447.7%
2023-05-16 6 22 9 13.800 2.84 385.92%
2023-08-11 6 22 8 12.666 2.91 335.26%
2023-10-11 7 22 8 12.285 2.31 431.82%
2023-10-11 7 22 8 12.500 2.31 441.13%

ERAS Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 6 0 0 0 0 6

The Trend in the Broker Recommendations


ERAS's average broker recommendation rating improved by 0.67 over the prior 13 months.

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • To contextualize these metrics, consider that out of all US stocks, ERASCA INC's upside potential (average analyst target price relative to current price) is higher than 2768.42% of them.
  • In the context of all US stocks, ERASCA INC's number of analysts covering the stock is higher than 565.74% of them.
  • ERASCA INC's variance in analysts' estimates is lower than -2157.13% of stocks in the mid market cap category.
  • ERAS has a higher average analyst price target than 721.89% of stocks in the mid market cap category.

Stocks similar to ERASCA INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are NUVL, VTYX, and BHVN.

Is ERAS a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!